187 related articles for article (PubMed ID: 9414105)
1. The rate-limiting steps for the folding of an antibody scFv fragment.
Jäger M; Plückthun A
FEBS Lett; 1997 Nov; 418(1-2):106-10. PubMed ID: 9414105
[TBL] [Abstract][Full Text] [Related]
2. Folding and assembly of an antibody Fv fragment, a heterodimer stabilized by antigen.
Jäger M; Plückthun A
J Mol Biol; 1999 Feb; 285(5):2005-19. PubMed ID: 9925781
[TBL] [Abstract][Full Text] [Related]
3. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
Jäger M; Gehrig P; Plückthun A
J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.
Jäger M; Plückthun A
Protein Sci; 2000 Mar; 9(3):552-63. PubMed ID: 10752617
[TBL] [Abstract][Full Text] [Related]
5. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
Lilie H; Rudolph R; Buchner J
J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
[TBL] [Abstract][Full Text] [Related]
6. Parallel pathways in the folding of a short-term denatured scFv fragment of an antibody.
Freund C; Gehrig P; Baici A; Holak TA; Plückthun A
Fold Des; 1998; 3(1):39-49. PubMed ID: 9502319
[TBL] [Abstract][Full Text] [Related]
7. Domain interactions in antibody Fv and scFv fragments: effects on unfolding kinetics and equilibria.
Jäger M; Plückthun A
FEBS Lett; 1999 Dec; 462(3):307-12. PubMed ID: 10622716
[TBL] [Abstract][Full Text] [Related]
8. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
Ramm K; Gehrig P; Plückthun A
J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanism and catalysis of a native-state prolyl isomerization reaction.
Pappenberger G; Bachmann A; Müller R; Aygün H; Engels JW; Kiefhaber T
J Mol Biol; 2003 Feb; 326(1):235-46. PubMed ID: 12547205
[TBL] [Abstract][Full Text] [Related]
10. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
11. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
12. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization.
Thies MJ; Mayer J; Augustine JG; Frederick CA; Lilie H; Buchner J
J Mol Biol; 1999 Oct; 293(1):67-79. PubMed ID: 10512716
[TBL] [Abstract][Full Text] [Related]
13. Kinetic models for unfolding and refolding of ribonuclease T1 with substitution of cis-proline 39 by alanine.
Mayr LM; Schmid FX
J Mol Biol; 1993 Jun; 231(3):913-26. PubMed ID: 8515460
[TBL] [Abstract][Full Text] [Related]
14. Catalysis of protein folding by prolyl isomerase.
Lang K; Schmid FX; Fischer G
Nature; 1987 Sep 17-23; 329(6136):268-70. PubMed ID: 3306408
[TBL] [Abstract][Full Text] [Related]
15. The rate of isomerisation of peptidyl-proline bonds as a probe for interactions in the physiological denatured state of chymotrypsin inhibitor 2.
Tan YJ; Oliveberg M; Otzen DE; Fersht AR
J Mol Biol; 1997 Jun; 269(4):611-22. PubMed ID: 9217264
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of a native-state prolyl isomerization.
Jakob RP; Schmid FX
J Mol Biol; 2009 Apr; 387(4):1017-31. PubMed ID: 19232524
[TBL] [Abstract][Full Text] [Related]
17. Folding nuclei of the scFv fragment of an antibody.
Freund C; Honegger A; Hunziker P; Holak TA; Plückthun A
Biochemistry; 1996 Jun; 35(25):8457-64. PubMed ID: 8679604
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment.
Arndt KM; Müller KM; Plückthun A
Biochemistry; 1998 Sep; 37(37):12918-26. PubMed ID: 9737871
[TBL] [Abstract][Full Text] [Related]
19. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
Nieba L; Honegger A; Krebber C; Plückthun A
Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
[TBL] [Abstract][Full Text] [Related]
20. A kinetic trap is an intrinsic feature in the folding pathway of single-chain Fv fragments.
Hoyer W; Ramm K; Plückthun A
Biophys Chem; 2002 May; 96(2-3):273-84. PubMed ID: 12034446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
